Use of biologics in the treatment of childhood rheumatic diseases.
- 1 August 2000
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Rheumatology Reports
- Vol. 2 (4), 330-336
- https://doi.org/10.1007/s11926-000-0071-1
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Soluble intercellular adhesion molecule‐1 in paediatric connective tissue diseasesActa Paediatrica, 1999
- Absence of association between interleukin 1 alpha and oligoarticular juvenile chronic arthritis in UK patientsRheumatology, 1999
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.JCI Insight, 1998
- A POSSIBLE ROLE FOR SOLUBLE IL-6 RECEPTOR IN THE PATHOGENESIS OF SYSTEMIC ONSET JUVENILE CHRONIC ARTHRITISCytokine, 1998
- A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritisArthritis & Rheumatism, 1996
- Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1Arthritis & Rheumatism, 1994
- Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritisClinical and Experimental Immunology, 1994
- Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.JCI Insight, 1994
- Amelioration of antigen‐induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion moleculesArthritis & Rheumatism, 1992
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990